Groove Botanicals Inc. (GRVE) EBT (2010 - 2026)
Groove Botanicals' (GRVE) quarterly EBT came in at -$28318.0 in Q2 2026, up 25.81% year-over-year from -$22508.4 in Q2 2025, and up 20.22% quarter-over-quarter from -$35497.0 in Q1 2026.
Analysis
Groove Botanicals Inc. (GRVE) EBT (2010 - 2026) Analysis & Trends
Groove Botanicals has disclosed EBT across 13 years of filings, most recently posting -$28318.0 for Q2 2026.
- In Q2 2026, EBT rose 25.81% year-over-year to -$28318.0; the TTM figure through Jun 2026 stood at -$130065.0 (up 1.81% YoY), while the FY2026 annual figure was -$139917.0, down 6.94% from the prior year.
- EBT came in at -$28318.0 for Q2 2026 at Groove Botanicals, up from -$35497.0 in the prior quarter.
- In the past five years, EBT ranged from a high of -$28318.0 in Q2 2026 to a low of -$126227.0 in Q2 2023.
- Average EBT over 5 years is -$45317.8, with a median of -$36018.0 recorded in 2024.
- Year-over-year, EBT slumped 39.08% in 2023 and jumped 71.05% in 2024.
- Over 5 years, EBT stood at -$41305.0 in 2022, then plunged by 39.08% to -$57446.0 in 2023, then jumped by 42.5% to -$33031.0 in 2024, then dropped by 2.53% to -$33867.0 in 2025, then rose by 16.38% to -$28318.0 in 2026.
- Per Business Quant data, the three most recent EBT figures were -$28318.0 in Q2 2026, -$35497.0 in Q1 2026, and -$33867.0 in Q4 2025.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28,318.00 |
| Mar 31, 2026 | -35,497.00 |
| Dec 31, 2025 | -33,867.00 |
| Sep 30, 2025 | -32,383.00 |
| Jun 30, 2025 | -38,170.00 |
| Mar 31, 2025 | -31,430.00 |
| Dec 31, 2024 | -33,031.00 |
| Sep 30, 2024 | -29,833.00 |
| Jun 30, 2024 | -36,539.00 |
| Mar 31, 2024 | -59,613.00 |
| Dec 31, 2023 | -57,446.00 |
| Sep 30, 2023 | -30,045.00 |
| Jun 30, 2023 | -126,227.00 |
| Mar 31, 2023 | -62,149.00 |
| Dec 31, 2022 | -41,305.00 |
| Sep 30, 2022 | -49,232.00 |
| Dec 31, 2017 | -16,573.00 |
| Sep 30, 2017 | -32,503.00 |
| Jun 30, 2017 | -30,551.00 |
| Mar 31, 2017 | -58,255.00 |